CH630643A5 - Process for concentrating a placenta-specific glycoprotein. - Google Patents

Process for concentrating a placenta-specific glycoprotein. Download PDF

Info

Publication number
CH630643A5
CH630643A5 CH465377A CH465377A CH630643A5 CH 630643 A5 CH630643 A5 CH 630643A5 CH 465377 A CH465377 A CH 465377A CH 465377 A CH465377 A CH 465377A CH 630643 A5 CH630643 A5 CH 630643A5
Authority
CH
Switzerland
Prior art keywords
solution
placenta
protein
bound
buffer
Prior art date
Application number
CH465377A
Other languages
German (de)
English (en)
Inventor
Hans Dr Bohn
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of CH630643A5 publication Critical patent/CH630643A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CH465377A 1976-04-17 1977-04-14 Process for concentrating a placenta-specific glycoprotein. CH630643A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2616984A DE2616984C3 (de) 1976-04-17 1976-04-17 Verfahren zur Isolierung und Reinigung eines plazentenspezifischen Glycoproteins

Publications (1)

Publication Number Publication Date
CH630643A5 true CH630643A5 (en) 1982-06-30

Family

ID=5975638

Family Applications (2)

Application Number Title Priority Date Filing Date
CH465377A CH630643A5 (en) 1976-04-17 1977-04-14 Process for concentrating a placenta-specific glycoprotein.
CH800281A CH632091A5 (en) 1976-04-17 1981-12-15 Process for the preparation of an antiserum directed against placenta-specific glycoprotein

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH800281A CH632091A5 (en) 1976-04-17 1981-12-15 Process for the preparation of an antiserum directed against placenta-specific glycoprotein

Country Status (20)

Country Link
JP (1) JPS52154509A (fr)
AT (1) AT362057B (fr)
AU (1) AU517434B2 (fr)
BE (1) BE853711A (fr)
CA (1) CA1101847A (fr)
CH (2) CH630643A5 (fr)
DE (1) DE2616984C3 (fr)
DK (1) DK168577A (fr)
ES (2) ES457714A1 (fr)
FI (1) FI60875C (fr)
FR (1) FR2348222A1 (fr)
GB (1) GB1555197A (fr)
IE (1) IE44824B1 (fr)
IL (1) IL51883A (fr)
IT (1) IT1075832B (fr)
LU (1) LU77143A1 (fr)
NL (1) NL7703963A (fr)
NO (1) NO146747C (fr)
NZ (1) NZ183878A (fr)
SE (1) SE7704359L (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2640387C3 (de) * 1976-09-08 1981-01-22 Behringwerke Ag, 3550 Marburg Gewebespezifisches Protein und Verfahren zu dessen Herstellung
DE2720704C2 (de) * 1977-05-07 1986-09-25 Behringwerke Ag, 3550 Marburg Neues Glycoprotein, Verfahren zu seiner Herstellung und seine Verwendung
DE2745680A1 (de) * 1977-10-11 1979-04-12 Behringwerke Ag Kontrazeptives mittel
EP0029893B1 (fr) * 1979-11-02 1987-05-20 Karl Prof. Dr. Theurer Procédé de concentration des substances possédant une activité anticancereuse
DE3013724A1 (de) 1980-04-10 1981-10-15 Behringwerke Ag, 3550 Marburg Neues protein pp (pfeil abwaerts)9(pfeil abwaerts), verfahren zu seiner anreicherung und gewinnung sowieseine verwendung
DE3334405A1 (de) * 1983-09-23 1985-04-04 Behringwerke Ag, 3550 Marburg Membranassoziierte proteine (mp(pfeil abwaerts)2(pfeil abwaerts)), verfahren zu ihrer gewinnung sowie ihre verwendung
NZ212523A (en) * 1985-06-24 1989-01-06 Univ Massey Mobile phase for purification of proteins by high performance liquid chromatography
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
CA2190727C (fr) * 1994-05-19 2006-07-18 Sudhakar Kasina Ligands d'atomes donneurs d'azote et de soufre pontes et substitues par amines aromatiques, utilises en imagerie
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms

Also Published As

Publication number Publication date
DK168577A (da) 1977-10-18
NO146747C (no) 1982-12-01
FI771186A7 (fr) 1977-10-18
FR2348222B1 (fr) 1980-02-08
IE44824L (en) 1977-10-17
FI60875B (fi) 1981-12-31
IT1075832B (it) 1985-04-22
AU2431977A (en) 1978-10-19
LU77143A1 (fr) 1977-11-14
DE2616984B2 (de) 1981-01-29
JPS52154509A (en) 1977-12-22
AU517434B2 (en) 1981-07-30
DE2616984C3 (de) 1981-10-29
GB1555197A (en) 1979-11-07
NZ183878A (en) 1980-04-28
CH632091A5 (en) 1982-09-15
NO146747B (no) 1982-08-23
DE2616984A1 (de) 1977-10-20
NL7703963A (nl) 1977-10-19
IE44824B1 (en) 1982-04-07
ES462699A1 (es) 1978-07-01
ATA266377A (de) 1980-09-15
SE7704359L (sv) 1977-10-18
IL51883A (en) 1980-02-29
CA1101847A (fr) 1981-05-26
FR2348222A1 (fr) 1977-11-10
ES457714A1 (es) 1978-02-16
IL51883A0 (en) 1977-06-30
AT362057B (de) 1981-04-27
BE853711A (fr) 1977-10-18
NO771316L (no) 1977-10-18
FI60875C (fi) 1982-04-13

Similar Documents

Publication Publication Date Title
DE2322533C2 (de) Verfahren zum Binden von Immunoglobulin und Hilfsmittel zur Durchführung des Verfahrens
DE2322552C2 (de) Verfahren zum Abtrennen von Protein A aus Staphylococcus aureus aus einer Flüssigkeit
CH627187A5 (fr)
EP0009715B1 (fr) Protéine ubiquitaire de tissu PP8 et procédé pour sa préparation
DE2640387C3 (de) Gewebespezifisches Protein und Verfahren zu dessen Herstellung
DE2616984C3 (de) Verfahren zur Isolierung und Reinigung eines plazentenspezifischen Glycoproteins
EP0100522B1 (fr) Protéine PP17, procédé pour sa concentration et son obtention ainsi que son application
EP0060491A2 (fr) Protéine PP16, procédé d'enrichissement et d'isolement ainsi que son application
EP0101603B1 (fr) Protéine (PP13), procédé pour sa concentration et son obtention ainsi que son application
EP0014756A1 (fr) Protéine de tissu PP10 placenta spécifique et procédé pour son enrichissement
EP0037963B1 (fr) Protéine PP9, procédé de son isolation, ainsi que son utilisation
DE10029705A1 (de) Herstellung von IgY(AFc)-Antikörpern und deren Verwendung
EP0141326B1 (fr) Protéine PP20, procédé de sa récupération et son utilisation
EP0165476A2 (fr) Protéine de tissu PP18, son procédé d'obtention et son application
EP0029191B1 (fr) Protéine PP 11, procédé pour son isolation et son utilisation
DE3410694C2 (fr)
EP0151463B1 (fr) Protéine tissulaire PP19, procédé d'obtention et application
EP0137345B1 (fr) Protéines associées aux membranes (MP-2), leur procédé d'obtention et leur application
EP0282018A2 (fr) Procédé pour isoler des protéines de membrane de base de tissus humains et animaux
DE10065227A1 (de) Verfahren zur Isolierung und Reinigung von Eigelb-Antikörpern aus Vogeleiweiß und Verwendung von dadurch erhaltenen Eigelb-Antikörpern
DE2062558A1 (de) Mittel zur Diagnose von primärem Leberkrebs und Verfahren zur Her stellung desselben
DE2445677C2 (de) Hochmolekulares alpha-Globulin und Verfahren zu dessen Herstellung
DE2014957A1 (de) Verfahren zur Reinigung von Proteinen des Blutserums oder -plasmas von Acrinol
DE2612479A1 (de) Verfahren zur anreicherung des schwangerschaftsspezifischen beta tief 1- glycoproteins
AT349649B (de) Gewinnung von antiseren

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased